BIONDI ANDREA

Franco, G., Bruno, L., Alviano, A., Vankann, L., Brümmendorf, T., Guerra, F., et al. (2026). Cytopenia, Hypocellular Bone Marrow, and Shortened Telomere Length Beyond Biallelic Telomere Biology Gene Mutations. PEDIATRIC BLOOD & CANCER [10.1002/1545-5017.70150]. Detail

Peccatori, N., Coppola, M., Colombini, A., Silvestri, D., Bertorello, N., Kiren, V., et al. (2025). Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases. EJC PAEDIATRIC ONCOLOGY, 5(June 2025) [10.1016/j.ejcped.2024.100202]. Detail

Moretti, A., Buracchi, C., Napolitano, S., Baldini, V., Gaipa, G., Biondi, A., et al. (2025). Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion. BLOOD TRANSFUSION, 23(5), 443-460 [10.2450/BloodTransfus.952]. Detail

Peccatori, N., Brivio, E., Lissat, A., Bautista Sirvent, F., Salzer, E., Biondi, A., et al. (2025). Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials. CANCERS, 17(20) [10.3390/cancers17203322]. Detail

Ponzo, M., Drufuca, L., Buracchi, C., Sindoni, M., Nucera, S., Bugarin, C., et al. (2025). Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 13(10), 1-16 [10.1136/jitc-2025-011768]. Detail